Development of a Clinical Trial Specific Question Prompt List
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Memorial Sloan Kettering Cancer Center
Related studies linked through entity extraction aliases.
Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major
- Status
- COMPLETED
- Phase
- NA
A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT
- Status
- COMPLETED
- Phase
- NA
Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial
- Status
- COMPLETED
- Phase
- PHASE3
Improving Outcomes Assessment in Chronic GVHD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Sensory Morbidity Following Breast Surgery
- Status
- COMPLETED
- Phase
- N/A
Expressive Writing and Adjustment to Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility
- Status
- COMPLETED
- Phase
- NA
Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population
- Status
- COMPLETED
- Phase
- N/A
Differential Risks for Melanoma: p16 and DNA Repair
- Status
- COMPLETED
- Phase
- N/A